LAM
UTHR icon

LECAP Asset Management’s United Therapeutics UTHR Stock Holding History

LECAP Asset Management’s Portfolio UTHR Stock Details UTHR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$595K Buy
1,099
+130
+13% +$73.2K 0.26% 162
2026
Q1 		$575K Buy
969
+273
+39% +$136K 0.22% 179
2025
Q4 		$339K Buy
+696
New +$324K 0.14% 228
2025
Q3 		– Sell
-2,321
Closed -$667K – 397
2025
Q2 		$667K Buy
+2,321
New +$694K 0.24% 164
2024
Q4 		– Sell
-1,346
Closed -$482K – 416
2024
Q3 		$482K Buy
+1,346
New +$455K 0.1% 267
2024
Q2 		– Sell
-2,432
Closed -$559K – 430
2024
Q1 		$559K Buy
2,432
+1,011
+71% +$228K 0.12% 250
2023
Q4 		$312K Buy
+1,421
New +$328K 0.11% 253

Other funds holding UTHR

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Norges Bank
Norges Bank Oslo, Norway $1T AUM

LECAP Asset Management's UTHR Position: Q2 2026 in Review

LECAP Asset Management increased its United Therapeutics (UTHR) stake by 13% in Q2 2026, buying an estimated $73.2K and bringing the position to 1,099 shares worth $595K. The position accounts for 0.26% of the portfolio, ranked #162.

LECAP Asset Management first reported a position in UTHR in Q4 2023 and has held it in 7 quarters since. The position peaked at $667K in Q2 2025. 875 funds tracked by Wall St. Rank hold UTHR as of Q2 2026.

  • LECAP Asset Management held 1,099 shares of United Therapeutics worth $595K as of Q2 2026.
  • LECAP Asset Management bought 130 United Therapeutics shares in Q2 2026, an estimated $73.2K.
  • United Therapeutics made up 0.26% of LECAP Asset Management's portfolio in Q2 2026, its #162 holding.
  • LECAP Asset Management first reported a position in United Therapeutics in Q4 2023 and has held it in 7 quarters since.
  • LECAP Asset Management's United Therapeutics position peaked at $667K in Q2 2025.
  • 875 funds tracked by Wall St. Rank held United Therapeutics as of Q2 2026.

Based on LECAP Asset Management's 13F filing for Q2 2026, filed 30 Jul 2026.